首页> 美国卫生研究院文献>Memrias do Instituto Oswaldo Cruz >Structure-based drug design studies of the interactions ofent-kaurane diterpenes derived from Wedeliapaludosa with the Plasmodium falciparumsarco/endoplasmic reticulum Ca2+-ATPase PfATP6
【2h】

Structure-based drug design studies of the interactions ofent-kaurane diterpenes derived from Wedeliapaludosa with the Plasmodium falciparumsarco/endoplasmic reticulum Ca2+-ATPase PfATP6

机译:基于结构的药物设计研究的相互作用衍生自Wedelia的对-月桂烷二萜paludosa与恶性疟原虫肌/内质网Ca2 + -ATPase PfATP6

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Malaria is responsible for more deaths around the world than any other parasitic disease. Due to the emergence of strains that are resistant to the current chemotherapeutic antimalarial arsenal, the search for new antimalarial drugs remains urgent though hampered by a lack of knowledge regarding the molecular mechanisms of artemisinin resistance. Semisynthetic compounds derived from diterpenes from the medicinal plant Wedelia paludosa were tested in silico against the Plasmodium falciparum Ca2+-ATPase, PfATP6. This protein was constructed by comparative modelling using the three-dimensional structure of a homologous protein, 1IWO, as a scaffold. Compound 21 showed the best docking scores, indicating a better interaction with PfATP6 than that of thapsigargin, the natural inhibitor. Inhibition of PfATP6 by diterpene compounds could promote a change in calcium homeostasis, leading to parasite death. These data suggest PfATP6 as a potential target for the antimalarial ent-kaurane diterpenes.
机译:疟疾比其他任何寄生虫病造成的死亡人数更多。由于出现了对目前的化学抗疟药库有抗药性的菌株,尽管缺乏有关青蒿素抗药性分子机制的知识阻碍了寻找新的抗疟药的工作仍然是紧迫的。在计算机上对恶性疟原虫Ca 2 + -ATPase PfATP6进行了来自药用植物Wedelia paludosa的二萜半合成化合物的测试。通过使用同源蛋白1IWO的三维结构作为支架,通过比较建模来构建该蛋白。化合物21显示出最佳的对接得分,表明与PfATP6的相互作用比天然抑制剂thapsigargin更好。二萜化合物对PfATP6的抑制作用可促进钙稳态的变化,从而导致寄生虫死亡。这些数据表明,PfATP6是抗疟原戊烷双萜类化合物的潜在靶标。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号